Search
enVVeno Medical Corp
NVNOAdd to Watchlist
9.100USD
0.0000.00%
Market hours 09/22, 10:45（ET）
6.10MMarket Cap
LossP/E TTM
enVVeno Medical Corp (NVNO) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to enVVeno Medical Corp in the past month.
Strong Buy
1 Strong Buy
0 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
30.000USD+234.26%
NVNO Analyst Recommendation Trends
In the current month, NVNO has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NVNO average Analyst price target in the last month is 30.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
1
1
1
1
NVNO Analyst Rating for Peer Comparison
Updated: Sep 22, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
11
14
3
0
0
28
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
8
13
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
7
7
1
1
21
Financial Forecasting
Based on analysts' estimates, NVNO EPS is projected to reach -3.270 in FY2026Q3, following reported EPS of -5.365 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.28
-8.40
-4.69
-3.27
-2.35
Actual
-6.05
-5.89
-5.37
--
--
Surprise
-2061.84%
+29.94%
-14.40%
--
--
FAQs
What is enVVeno Medical Corp's price target?
Analysts forecast that enVVeno Medical Corp's price target is USD 30.00, with the highest forecast at USD 30.00 and the lowest forecast at USD 30.00.
How have enVVeno Medical CorpNVNO's recent earnings per share performed?
The market expectation was USD -5.37, while enVVeno Medical CorpNVNO's earnings per share (EPS) for the previous quarter was USD -5.89. EPS for the next quarter is expected at USD -3.27.
What is the analyst rating for enVVeno Medical Corp?
Based on the ratings of enVVeno Medical Corp's stock from 1 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.